These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36925875)

  • 1. An Opportunity to Harmonise the Approach to Patients' Care Pathways for Rare and Complex Diseases: RarERN Path™.
    Talarico R; Marinello D; Cannizzo S; Palla I; Ticciati S; Gaglioti A; Rys A; Milli C; Taruscio D; Mosca M; Turchetti G
    Front Health Serv; 2022; 2():935014. PubMed ID: 36925875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks.
    Talarico R; Cannizzo S; Lorenzoni V; Marinello D; Palla I; Pirri S; Ticciati S; Trieste L; Triulzi I; Terol E; Bucher A; Turchetti G
    Orphanet J Rare Dis; 2020 Dec; 15(1):347. PubMed ID: 33317578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shaping the Future of Rare Diseases after a Global Health Emergency: Organisational Points to Consider.
    Talarico R; Marinello D; Cannizzo S; Gaglioti A; Ticciati S; Carta C; Kodra Y; Azadegan M; Taruscio D; Mosca M; Turchetti G
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33238523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.
    Talarico R; Aguilera S; Alexander T; Amoura Z; Andersen J; Arnaud L; Avcin T; Marsal Barril S; Beretta L; Bombardieri S; Bortoluzzi A; Bouillot C; Bulina I; Burmester GR; Cannizzo S; Cavagna L; Chaigne B; Cornet A; Corti P; Costedoat-Chalumeau N; Dāvidsone Z; Doria A; Fenech C; Ferraris A; Fischer-Betz R; Fonseca JE; Frank C; Gaglioti A; Galetti I; Guimarães V; Hachulla E; Holmner M; Houssiau F; Iaccarino L; Jacobsen S; Limper M; Malfait F; Mariette X; Marinello D; Martin T; Matthews L; Matucci-Cerinic M; Meyer A; Milas-Ahić J; Moinzadeh P; Montecucco C; Mouthon L; Müller-Ladner U; Nagy G; Patarata E; Pileckyte M; Pruunsild C; Rednic S; Romão VC; Schneider M; Scirè CA; Smith V; Sulli A; Tamirou F; Tani C; Taruscio D; Taulaigo AV; Tincani A; Ticciati S; Turchetti G; van Hagen PM; van Laar JM; Viera A; de Vries-Bouwstra JK; Zschocke J; Cutolo M; Mosca M
    Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):3-11. PubMed ID: 35349419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations.
    Taruscio D; Gentile AE; Evangelista T; Frazzica RG; Bushby K; Montserrat AM
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s621-5. PubMed ID: 24922304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Healthcare networks for people with rare diseases: integrating data and expertise].
    Graessner H; Storf H; Schaefer F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1164-1169. PubMed ID: 36167994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing rare disease care pathways in the Republic of Ireland: a co-operative model.
    Ward AJ; Murphy D; Marron R; McGrath V; Bolz-Johnson M; Cullen W; Daly A; Hardiman O; Lawlor A; Lynch SA; MacLachlan M; McBrien J; Ni Bhriain S; O'Byrne JJ; O'Connell SM; Turner J; Treacy EP
    Orphanet J Rare Dis; 2022 Apr; 17(1):162. PubMed ID: 35410222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The context for the thematic grouping of rare diseases to facilitate the establishment of European Reference Networks.
    Evangelista T; Hedley V; Atalaia A; Johnson M; Lynn S; Le Cam Y; Bushby K
    Orphanet J Rare Dis; 2016 Feb; 11():17. PubMed ID: 26911987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.
    Hassan IF; Alinier G
    Qatar Med J; 2019; 2019(2):1. PubMed ID: 31763204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction to: RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks.
    Talarico R; Cannizzo S; Lorenzoni V; Marinello D; Palla I; Pirri S; Ticciati S; Trieste L; Triulzi I; Terol E; Bucher A; Turchetti G
    Orphanet J Rare Dis; 2021 Mar; 16(1):146. PubMed ID: 33752690
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of rare cancers and inequalities in oncologic outcomes.
    Gatta G; Trama A; Capocaccia R;
    Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [European Reference Network for Rare Hepatological Diseases (ERN RARE-LIVER)].
    Schulz L; Sebode M; Schramm C; Lohse AW
    Internist (Berl); 2021 Apr; 62(4):441-448. PubMed ID: 33687527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Reference Network for Rare Neurological Diseases.
    Reinhard C; Bachoud-Lévi AC; Bäumer T; Bertini E; Brunelle A; Buizer AI; Federico A; Gasser T; Groeschel S; Hermanns S; Klockgether T; Krägeloh-Mann I; Landwehrmeyer GB; Leber I; Macaya A; Mariotti C; Meissner WG; Molnar MJ; Nonnekes J; Ortigoza Escobar JD; Pérez Dueñas B; Renna Linton L; Schöls L; Schuele R; Tijssen MAJ; Vandenberghe R; Volkmer A; Wolf NI; Graessner H
    Front Neurol; 2020; 11():616569. PubMed ID: 33519696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.